228 related articles for article (PubMed ID: 15604418)
1. ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells.
Wang L; Olivecrona G; Götberg M; Olsson ML; Winzell MS; Erlinge D
Circ Res; 2005 Feb; 96(2):189-96. PubMed ID: 15604418
[TBL] [Abstract][Full Text] [Related]
2. Modulation of neurotransmitter release by P2X and P2Y receptors in the rat spinal cord.
Heinrich A; Kittel A; Csölle C; Sylvester Vizi E; Sperlágh B
Neuropharmacology; 2008 Feb; 54(2):375-86. PubMed ID: 18063000
[TBL] [Abstract][Full Text] [Related]
3. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
4. ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways.
Shen J; DiCorleto PE
Circ Res; 2008 Feb; 102(4):448-56. PubMed ID: 18174464
[TBL] [Abstract][Full Text] [Related]
5. ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels.
Wihlborg AK; Wang L; Braun OO; Eyjolfsson A; Gustafsson R; Gudbjartsson T; Erlinge D
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1810-5. PubMed ID: 15308557
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of the human P2Y13 receptor.
Marteau F; Le Poul E; Communi D; Communi D; Labouret C; Savi P; Boeynaems JM; Gonzalez NS
Mol Pharmacol; 2003 Jul; 64(1):104-12. PubMed ID: 12815166
[TBL] [Abstract][Full Text] [Related]
7. Involvement of multiple P2Y receptors and signaling pathways in the action of adenine nucleotides diphosphates on human monocyte-derived dendritic cells.
Marteau F; Communi D; Boeynaems JM; Suarez Gonzalez N
J Leukoc Biol; 2004 Oct; 76(4):796-803. PubMed ID: 15240747
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
von Kügelgen I
Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
[TBL] [Abstract][Full Text] [Related]
9. P2Y13 receptors mediate presynaptic inhibition of acetylcholine release induced by adenine nucleotides at the mouse neuromuscular junction.
Guarracino JF; Cinalli AR; Fernández V; Roquel LI; Losavio AS
Neuroscience; 2016 Jun; 326():31-44. PubMed ID: 27058149
[TBL] [Abstract][Full Text] [Related]
10. ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice.
Amisten S; Meidute-Abaraviciene S; Tan C; Olde B; Lundquist I; Salehi A; Erlinge D
Diabetologia; 2010 Sep; 53(9):1927-34. PubMed ID: 20526761
[TBL] [Abstract][Full Text] [Related]
11. Regulation of rat hepatocyte function by P2Y receptors: focus on control of glycogen phosphorylase and cyclic AMP by 2-methylthioadenosine 5'-diphosphate.
Dixon CJ; Hall JF; Webb TE; Boarder MR
J Pharmacol Exp Ther; 2004 Oct; 311(1):334-41. PubMed ID: 15152027
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the influence of nucleotidases on the apparent activity of exogenous ATP and ADP at P2Y1 receptors.
Vigne P; Breittmayer JP; Frelin C
Br J Pharmacol; 1998 Oct; 125(4):675-80. PubMed ID: 9831901
[TBL] [Abstract][Full Text] [Related]
13. Reference curves for aggregation and ATP secretion to aid diagnose of platelet-based bleeding disorders: effect of inhibition of ADP and thromboxane A(2) pathways.
Dawood BB; Wilde J; Watson SP
Platelets; 2007 Aug; 18(5):329-45. PubMed ID: 17654303
[TBL] [Abstract][Full Text] [Related]
14. The P2Y(1) and P2Y(12) receptors mediate autoinhibition of transmitter release in sympathetic innervated tissues.
Quintas C; Fraga S; Gonçalves J; Queiroz G
Neurochem Int; 2009 Dec; 55(7):505-13. PubMed ID: 19447154
[TBL] [Abstract][Full Text] [Related]
15. The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis.
Jacquet S; Malaval C; Martinez LO; Sak K; Rolland C; Perez C; Nauze M; Champagne E; Tercé F; Gachet C; Perret B; Collet X; Boeynaems JM; Barbaras R
Cell Mol Life Sci; 2005 Nov; 62(21):2508-15. PubMed ID: 16231090
[TBL] [Abstract][Full Text] [Related]
16. Release and interconversion of P2 receptor agonists by human osteoblast-like cells.
Buckley KA; Golding SL; Rice JM; Dillon JP; Gallagher JA
FASEB J; 2003 Aug; 17(11):1401-10. PubMed ID: 12890693
[TBL] [Abstract][Full Text] [Related]
17. P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells.
Wang L; Jacobsen SE; Bengtsson A; Erlinge D
BMC Immunol; 2004 Aug; 5():16. PubMed ID: 15291969
[TBL] [Abstract][Full Text] [Related]
18. ATP-stimulated ANP release through P1 receptor subtype.
Cao C; Piao FL; Han JH; Kim SZ; Kim SH
Regul Pept; 2005 Apr; 127(1-3):37-43. PubMed ID: 15680468
[TBL] [Abstract][Full Text] [Related]
19. The role of purinergic P2Y
Villanueva-Castillo B; Rivera-Mancilla E; Haanes KA; MaassenVanDenBrink A; Villalón CM
Purinergic Signal; 2020 Mar; 16(1):73-84. PubMed ID: 32067141
[TBL] [Abstract][Full Text] [Related]
20. The ADP receptor P2Y(1) mediates t-PA release in pigs during cardiac ischemia.
Olivecrona GK; Götberg M; Harnek J; Jacobson KA; Jern S; Erlinge D
J Thromb Thrombolysis; 2007 Oct; 24(2):115-22. PubMed ID: 17294140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
